Clinical trial

Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy

NCT00122655

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2001-01-01

PhasePHASE4

Study timeline

Study start (unknown)2001-01-01Date precision: month

Registry last updated2005-11-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

HIV Lipodystrophy Syndromeunresolved

Interventions

non-nucleoside reverse transcriptase inhibitorsDRUG

nucleoside reverse transcriptase inhibitorsDRUG

protease inhibitorsDRUG

Sponsors & collaborators

French National Agency for Research on AIDS and Viral Hepatitislead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00122655 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.